Rep. Jen Dailey-Provost

Maddy summaryHB 500 classifies amanita muscaria (a psychoactive mushroom) as a controlled substance under Utah's Schedule I, making its possession or distribution illegal. It also creates a mechanism where certain psilocybin products would automatically be rescheduled if the federal government reschedules them. This bill directly affects Utah residents who might possess or use these substances, particularly those using amanita muscaria products. The changes take effect immediately upon passage, with no new funding required, and align Utah's laws with potential federal actions on psilocybin.

Maddy summaryHB 509 updates Utah's regulations for specialized products, primarily affecting kratom sellers and related agencies. It sets new requirements for selling kratom, including mandatory labeling of alkaloid content, restrictions on certain ingredients, and mandatory registration with the Department of Agriculture. The bill also renames the "Cannabinoid Proceeds Restricted Account" to "Specialized Product Proceeds Restricted Account" and applies a new tax on kratom products to fund enforcement and other state duties. These changes directly impact businesses selling kratom and the agencies responsible for product safety oversight and tax collection.

Maddy summaryHB 203 amends Utah's medical cannabis regulations to expand pharmacy options and clarify rules. It creates a new license for independent medical cannabis pharmacies, adds ownership restrictions for these pharmacies, and adjusts licensing fees. The bill modifies production and sanitation requirements for cannabis facilities, allows processing facilities to display product information online, and repeals outdated sections about a central patient portal. These changes directly affect medical cannabis pharmacies, patients, and the Department of Agriculture and Food overseeing compliance.

Maddy summaryHJR 2 modifies Utah's process for preparing fiscal notes, which estimate the cost of proposed legislation. It requires the legislative fiscal analyst to review bills and issue notes within three business days (with limited extensions for complex issues like retirement benefits), and gives sponsors a 24-hour window to request the note be held, approve its release, or discuss disagreements. If sponsors don't respond within that period, the fiscal note is automatically released. The note itself is not part of the legislation but will be printed alongside it. This procedural change affects legislative sponsors and the fiscal analyst as they handle budget impact assessments.

Maddy summaryHB 523 creates a 10-member "Rio Grande Financial Advisory Authority" working group to identify funding sources for the Rio Grande Plan, which aims to restore rail service to Salt Lake City's Rio Grande Depot and eliminate at-grade rail crossings. The working group, including state legislators, Salt Lake City representatives, transit officials, and community council members, will meet every two months from May 2025 to May 2026 to study implementation, eminent domain issues, and potential impacts. It must identify federal, state, and other funding options and make recommendations to the Governor's Office of Economic Opportunity and Salt Lake City by July 2026. The bill does not appropriate funds but requires the group to report to the Transportation Interim Committee and provide recommendations to relevant entities.

Maddy summaryHB 314 (Breast Cancer Prevention Modifications) prohibits health insurance plans in Utah from requiring patients to pay copays, deductibles, or other out-of-pocket costs for specific breast examinations. It defines "diagnostic" exams (for known abnormalities) and "supplemental" exams (for screening based on risk factors like family history), covering mammograms, MRIs, ultrasounds, and contrast-enhanced mammography. Insurance plans must cover these exams without cost-sharing if they align with National Comprehensive Cancer Network Guidelines. The law takes effect May 7, 2025, and directly affects all health benefit plans offering breast cancer screening coverage in Utah.

Maddy summaryThis bill requires Utah pharmacies to provide accessible prescription labels in large-print, braille, or audio format when a patient identifies as visually impaired and requests one. It amends existing pharmacy labeling laws (Utah Code § 58-17b-602) to mandate this change, directly affecting visually impaired patients and pharmacies dispensing prescriptions. Pharmacies must offer these labels in a timely manner matching standard patient wait times and accommodate individual device preferences for audio labels. The policy change takes effect May 7, 2026, with no new funding required.

Maddy summaryHB 170 modifies Utah's process for statewide initiatives and referendums. It requires the Office of Legislative Research to create impartial summaries of proposed laws or laws a referendum seeks to overturn, which must be included in signature packets instead of the full law text. Petition signers must read these summaries but are not required to understand them. The bill affects voters signing initiative or referendum petitions and organizers gathering signatures, clarifying procedures for petition reviews and summary challenges.